ArticleTherapeutic advances in musculoskeletal disease2020

Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease: when dosage matters in overcoming secondary therapy resistance.

Sofia Ajeganova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.